Press release
Chantal Friebertshäuser Joins Moderna as Senior Vice President, Commercial
Newly created role will have responsibility for commercial efforts in Europe, Middle East and CanadaCAMBRIDGE, MA / ACCESSWIRE / December 20, 2022 / Moderna,
About this update from Moderna, Inc.
[{"type":"text","content":"Newly created role will have responsibility for commercial efforts in Europe, Middle East and CanadaCAMBRIDGE, MA / ACCESSWIRE / December 20, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced the appointment of Chantal Friebertshäuser as Senior Vice President, Commercial, Europe, Middle East and Canada effective January 1, 2023. Ms. Friebertshäuser will be responsible for commercial efforts in Europe, Middle East and Canada, reporting to Arpa Garay, Moderna's Chief Commercial Officer.\"Chantal has extensive experience in leading global teams and scaling commercial organizations regionally,\" said Arpa Garay, Moderna's Chief Commercial Officer. \"Her insights, drive and commitment to patients will be instrumental as we enter new markets and advance our platform-based approach to medicine. Having worked with her previously, I know first-hand that she will be a terrific addition to the organization.\"Ms. Friebertshäuser joins Moderna from Merck Sharp & Dohme (MSD), where she served in a variety of in-market and global commercial leadership roles across 15 years, including her most recent position of Human Health Senior Vice President and Managing Director at MSD Germany. In this role, Ms. Friebertshäuser was responsible for the company's Human Health Organization and also led the MSD Country Council which convened leaders from the organization's Human Health, Animal Health, Research and Manufacturing sites. Other prior roles include German Business Unit Leader, Global Market Access Leader, Managing Director of Austria and Global Commercial Lead for the company's HPV vaccine franchise. Prior to MSD, Ms. Friebertshäuser spent 10 years in various roles at Eli Lilly.\"Over the course of my career, I've always had a deep passion for bringing forward business solutions that improve lives, while also building diverse teams unified by a common, impactful mission,\" said Ms. Friebertshäuser. \"I am thrilled to join Moderna and the mission to transform medicine - and the world - through the promise of mRNA and look forward to expanding its presence in Europe, Middle-East and Canada.\"Ms. Friebertshäuser holds a Master of Arts in International Business from the School of Business ESC in Rennes, France. She will be based in Switzerland.About ModernaIn over 10 ...